- Home
- NRSN vs SPAI Comparison
NRSN vs SPAI Comparison
Compare NRSN & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- SPAI
- Stock Information
- Founded
- NRSN 2017
- SPAI 2021
- Country
- NRSN Israel
- SPAI United States
- Employees
- NRSN N/A
- SPAI N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- SPAI Industrial Specialties
- Sector
- NRSN Health Care
- SPAI Health Care
- Exchange
- NRSN Nasdaq
- SPAI Nasdaq
- Market Cap
- NRSN 45.3M
- SPAI 38.5M
- IPO Year
- NRSN 2021
- SPAI 2024
- Fundamental
- Price
- NRSN $1.91
- SPAI $2.64
- Analyst Decision
- NRSN Buy
- SPAI
- Analyst Count
- NRSN 2
- SPAI 0
- Target Price
- NRSN $14.00
- SPAI N/A
- AVG Volume (30 Days)
- NRSN 427.0K
- SPAI 39.0K
- Earning Date
- NRSN 07-15-2025
- SPAI 08-15-2025
- Dividend Yield
- NRSN N/A
- SPAI N/A
- EPS Growth
- NRSN N/A
- SPAI N/A
- EPS
- NRSN N/A
- SPAI N/A
- Revenue
- NRSN N/A
- SPAI $2,046,327.00
- Revenue This Year
- NRSN N/A
- SPAI N/A
- Revenue Next Year
- NRSN N/A
- SPAI N/A
- P/E Ratio
- NRSN N/A
- SPAI N/A
- Revenue Growth
- NRSN N/A
- SPAI 140.22
- 52 Week Low
- NRSN $0.51
- SPAI $1.47
- 52 Week High
- NRSN $2.60
- SPAI $6.50
- Technical
- Relative Strength Index (RSI)
- NRSN 48.94
- SPAI N/A
- Support Level
- NRSN $1.81
- SPAI N/A
- Resistance Level
- NRSN $1.96
- SPAI N/A
- Average True Range (ATR)
- NRSN 0.20
- SPAI 0.00
- MACD
- NRSN -0.08
- SPAI 0.00
- Stochastic Oscillator
- NRSN 19.10
- SPAI 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.